At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01541 IMMUNEONCO-B
Not Yet Opened 12-20 16:08:10
5.030
-0.250
-4.73%
High5.340
Low4.960
Vol10.10M
Open5.340
D1 Closing5.280
Amplitude7.20%
Mkt Cap2.05B
Tradable Cap1.92B
Total Shares407.00M
T/O51.66M
T/O Rate2.64%
Tradable Shares382.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
ImmuneOnco Biopharmaceuticals Doses 1st Patient in NMOSD Drug Trial
ImmuneOnco Biopharmaceuticals Shanghai Inc is a China-based company mainly engaged in research and development of testing biotechnology. The Company's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The Company mainly operates its businesses in the domestic and overseas markets.